Ex Parte Nowakowski et alDownload PDFPatent Trial and Appeal BoardJan 11, 201712304823 (P.T.A.B. Jan. 11, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 12/304,823 06/29/2009 Sylvain Nowakowski 71172 8892 22847 7590 01/13/2017 SYNGENTA CROP PROTECTION LLC PATENT DEPARTMENT PO Box 12257 9 Davis Drive Research Triangle Park, NC 27709-2257 EXAMINER HOLT, ANDRIAE M ART UNIT PAPER NUMBER 1616 NOTIFICATION DATE DELIVERY MODE 01/13/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): global.patents @ syngenta. com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte SYLVAIN NOWAKOWSKI, BETH HALL, EDMOND SZTOR, VALERY TYSHKEVICH, VICTOR PYUSHPEKI, and OLGA BALLOD Appeal 2016-003743 Application 12/304,823 Technology Center 1600 Before DONALD E. ADAMS, JEFFREY N. FREDMAN, and RYAN H. FLAX, Administrative Patent Judges. ADAMS, Administrative Patent Judge. DECISION ON APPEAL1 This appeal under 35 U.S.C. § 134(a) involves claims 1, 2, 4, and 6— 10 (Br. 3). Examiner entered rejections under 35 U.S.C. § 103(a). We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 Appellants identify the real party in interest as “Syngenta Crop Protection, LLC” (Br. 3). Appeal 2016-003743 Application 12/304,823 STATEMENT OF THE CASE Appellants disclose “the use of a defined combination of pesticidal active ingredients, and compositions thereof, and methods for using such combinations in the control or prevention of pathogenic and/or pest damage” (Spec. 1). Claims 1 and 4 are representative and reproduced below: 1. A method of controlling pathogenic fungal damage in a plant propagation material, a plant, parts of a plant and/or plant organs that grow at a later point in time, which comprises applying on the plant, part of the plant, plant organs, plant propagation material or a surrounding area thereof a combination comprising (I) tebuconazole, (II) azoxystrobin and (III) fludioxonil, provided that where tefluthrin and thiamethoxam are both present, the combination comprises more than five active ingredients, wherein the mass ratio between any two active ingredients in the combination is from 10: 1 to 1 : 10. (Br. 26.) 4. The method according to claim 1 wherein the combination [comprises] tebuconazole, azoxystrobin, thiamethoxam and fludioxonil. {Id.2) 2 Appellants’ claim 4, as presented, appears to include a typographical error rendering the claim incomplete {see Br. 26). For the purposes of this Appeal, we interpret Appellants’ claim 4 as including the transitional term “comprises” between the words “combination” and “tebuconazole”. See, e.g., Br. 16 (“Appellants’ claimed invention, as embodied in dependent claim 4, is directed to the method according to claim 1 [], wherein the combination of active amterials used in the recited method of controlling pathogenic fungal damage comprises tebuconazole, axoxystrobin, thamethoxam and fluidioxonil”). 2 Appeal 2016-003743 Application 12/304,823 The claims stand rejected as follows: Claims 1, 2, 4, and 6—10 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Weiss3 and Schlatter ’103.4 Claims 1, 2, 4, and 6—10 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Schlatter ’333.5 The rejection over Schlatter ’333 is cumulative to the rejection over Weiss and Schlatter ’103. Therefore, we vacate, and will not further discuss, the rejection over Schlatter ’333. ISSUE Does the preponderance of evidence relied upon by Examiner support a conclusion of obviousness? FACTUAL FINDINGS (FF) FF 1. Weiss relates to a method for improving the growing characteristics of a plant, in particular by protecting the plant propagation material of the plant against damage by molluscs, [such as slugs and snails,] which method comprises a defined treatment of the plant propagation material; a plant propagation material so treated; and a composition for such treatment. (Weiss 1: 1—6 and 12; see generally Non-Final Act.6 4.) FF 2. Weiss discloses a composition (A), wherein a preferred combination of active agents includes: (A) at least three [active agents selected] from: (I) thiamethoxam, imidacloprid, clothianidin, tefluthrin, beta-cyfluthrin, cypermethrin, alpha-cypermethrin, 3 Weiss et al., WO 2006/128655 A2, published Dec. 7, 2006. 4 Schlatter et al., US 2005/0209103 Al, published Sept. 22, 2005. 5 Schlatter et al., WO 2006/024333 A2, published Mar. 9, 2006. 6 Examiner’s January 15, 2015 Non-Final Office Action. 3 Appeal 2016-003743 Application 12/304,823 beta-cypermethrin, theta-cypermethrin, zeta- cypermethrin, fipronil and metaldehyde; especially selected from thiamethoxam, imidacloprid, clothianidin, fipronil and metaldehyde, and (II) thiram, benalaxyl, benalaxyl-M, fuberdiazole, thiabendazole, azoxystrobin, pyraclostrobin, fluoxastrobin, bitertanol, cyproconazole, difenoconazole, prochloraz, diniconazole, prothioconazole, fluquinconazole, flutriafol, metalaxyl, metalaxyl-M, prothioconazole, tebuconazole, triadimenol, triticonazole, fludioxonil, triazoxide, cyprodinil, carboxin and silthiofam; especially pyraclostrobin, fluoxastrobin, fluquinconazole, prothioconazole, tebuconazole, carboxin, fludioxonil, prochloraz, difenoconazole, mefenoxam. (Weiss 14: 7—19 (emphasis added); see generally Ans. 5 and 10.) FF 3. Weiss discloses “[a] method of controlling mollusk damage to plants in horticulture or agriculture compris[ing] treating the plant’s propagation material with a combination of, as active ingredients, at least. . . thiamethoxam, tefluthrin, azoxystrobin and tebuconazole” (Weiss 23: 3—8; see Ans. 3). FF 4. Weiss identifies tebuconazole, azoxystrobin, and fludioxonil as fungicidal compounds (Weiss 5: 22—26; see generally Ans. 3). FF 5. Weiss discloses: The combinations of the invention demonstrate synergistically enhanced action resulting in, for example, reduced damage to the plant by molluscs, lower rates of application of the individual active ingredients for such control, a longer duration of action and all together higher crop yields. The increase in advantageous properties achieved with the combinations of the invention are significantly greater than the activity to be expected by the individual components. In particular, it has now been found, surprisingly, that, for example, the activity of 4 Appeal 2016-003743 Application 12/304,823 the treatment of the combinations of the invention on the plant propagation material, compared with the activity of the individual active ingredients, are not merely additive, as may essentially be expected, but that a synergistic effect exists. This effect can be calculated according to the Colby formula. (Weiss 3: 24—33; see generally Non-Final Act. 4; see also Weiss at 3: 35 — 4:13 (“The term ‘synergistic’, independently of the combination , is not, however, in any way limited in this context to the molluscicidal activity, but refers equally to other advantageous properties”).) FF 6. Weiss discloses that “[t]he weight ratio of any combination of active ingredients is generally selected as to give the desired, for example synergistic, action. In general, the weight ratio between any two active ingredients is from 7:1 to 1:7” (Weiss 9: 31—34; see Non-Final Act. 4; Ans. 9). FF 7. Examiner finds that while Weiss discloses a method of protecting plant propagation material against damage by molluscs, which comprises the administration of a composition comprising fungicides to the plant propagation material; Weiss “do[es] not specifically disclose a method of controlling pathogenic fungal disease by applying a combination of tebuconazole, azoxystrobin, and fludioxonil” and, therefore, relies on Schlatter ’103 to make up for this deficiency in Weiss (Non-Final Act. 5; cf. id. at 4—5). FF 8. Schlatter ’103 “relates to aqueous compositions, to the preparation of such compositions and to a method of using such compositions to combat phytopathogenic fungi” (Schlatter ’103 11; id. 118 (Schlatter ’103 “provides for plant propagation materials treated with the aqueous composition and for a method for reducing fungal infestation of plant propagation materials such as seeds”); see Non-Final Act. 5). 5 Appeal 2016-003743 Application 12/304,823 FF 9. Schlatter ’103 discloses: The term “fungicide” as utilized herein is intended to cover compounds active against phytopathogenic fungi that may belong to a very wide range of compound classes. Examples of compound classes to which the suitable fimgicidally active compound may belong include . . . fungicides such as: triazole derivatives, strobilurins, carbamates (including thio- and dithiocarbamates), benzimidazoles (thiabendazole), N-trihalomethylthio compounds (captan), substituted benzenes, carboxamides, phenylamides and phenylpyrroles, and mixtures thereof. (Schlatter ’103 120 (emphasis added); see Non-Final Act. 5 and 7.) FF 10. Schlatter ’103 discloses that “[sjuitable triazole derivatives include propiconazole, difenconazole, tebuconazole, tetraconazole and triticonazole;” “suitable strobilurins include trifloxystrobin, azoxystrobin, kresoxim-methyl and picoxystrobin;” and “a specific phenylpyrrole usable in the compositions and methods falling within the scope of [Schlatter ’ 103’s] invention is fludioxoniV (Schlatter ’103 22, 23, and 28 (emphasis added); see Non-Final Act. 5 and 9-10). FF 11. Schlatter ’103 discloses that “[mixtures of one or more of the foregoing fimgicidally active compounds also are usable as an active component in the practice of [Schlatter ’ 103 ’s] invention” (Schlatter ’103 131 ; see Non-Final Act. 5). FF 12. Appellants define [t]he term “plant propagation material” [as] all the generative parts of the plant, such as seeds, which can be used for the multiplication of the latter and vegetative plant materials such as cuttings and tubers (for example, potatoes). Accordingly, as used herein part of a plant includes propagation material. There may be mentioned, e.g., the seeds (in the strict sense), roots fruits, tubers, bulbs, rhizomes, parts of plants. Germinated plants and young plants, which are to be transplanted after 6 Appeal 2016-003743 Application 12/304,823 germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion. (Spec. 9: 1-9.) FF 13. Zeun tested the effect of compounds against fungi spores mixed with PDB potato dextrose broth (Zeun Dec.714). FF 14. Zeun concludes that “[t]he mixture of tebuconazole, azoxystrobin and fluidioxonil shows synergistic results for different pathogens across a variety of mixing ratios” (Zeun 5: 2—3). ANALYSIS The rejection over the combination of Weiss and Schlatter ’103: Weiss discloses “a method for improving the growing characteristics of a plant, in particular by protecting the plant propagation material of the plant against damage by molluscs,” wherein the method comprises treating the plant propagation material with a synergistically active composition that comprises, in addition to tefluthrin and thiamethoxam, the fungicidal compounds tebuconazole, azoxystrobin, and fludioxonil (FF 1—5). Schlatter ’ 103 discloses that azoxystrobin, and fludioxonil are effective against pathogenic fungi (FF 8—11). In addition, Weiss discloses that “the weight ratio between any two active ingredients is from 7:1 to 1:7” (FF 6). Therefore, we find no error in Examiner’s conclusion that based on the combination of Weiss and Schlatter ’103, it would have been prima facie obvious, at the time Appellants’ invention was made, to utilize the method of Weiss to control both mollusk and pathogenic fungal damage in a plant propagation material, wherein Weiss’ method comprises applying, to plant propagation material, a composition comprising tebuconazole, azoxystrobin, 7 Declaration of Ronald Zeun, signed Aug. 10, 2012. 7 Appeal 2016-003743 Application 12/304,823 fludioxonil, tefluthrin, and thiamethoxam (see Non-Final Act. 6; see also FF 1-11). Claim 1: Examiner relies upon Schlatter ’103 to disclose that the tebuconazole, azoxystrobin, fludioxonil fungicides disclosed by Weiss are effective against pathogenic fungi (see FF 8—11). Therefore, we are not persuaded by Appellants’ contentions that a person of ordinary skill in this art would not have considered Schlatter ’103 in the context of Weiss, or that Weiss “teaches away” for its combination with Schlatter ’103 (Br. 9—10). We are not persuaded by Appellants’ intimation that Weiss fails to suggest the selection of tebuconazole, azoxystrobin, fludioxonil, tefluthrin, and thiamethoxam as part of a composition comprising “at least three” of the compounds expressly disclosed by Weiss (see Br. 10-12; cf. FF 2-4). See Merck & Co. Inc. v. Biocraft Laboratories, Inc., 874 F.2d 804, 807 (Fed. Cir. 1989) (“Disclos[ure of] a multitude of effective combinations does not render any particular formulation less obvious”). For the foregoing reasons, we are not persuaded by Appellants’ contention that Examiner’s conclusion of obviousness is based in hindsight (Br. 11). We recognize, but are not persuaded by Appellants’ contentions regarding the Zeun declaration (Br. 12—16). Initially, we agree with Examiner that the Zeun declaration is not commensurate in scope with Appellants’ claimed invention (see generally Non-Final Act. 10—13; see also FF 12 (defining the term “plant propagation material”); cf. FF 13—14 (discussing results obtained from experiments on “PDB potato dextrose 8 Appeal 2016-003743 Application 12/304,823 broth”)). We find no persuasive evidence or argument on this record to support a conclusion that PDB potato dextrose broth falls within the scope of a plant propagation material as defined by Appellants’ Specification (see FF 13—14; cf FF 12). Nevertheless, the Zeun declaration and Appellants’ contentions based thereon relate to the synergism of some compounds within the scope of their claimed invention (see Br. 12—16; FF 14). Notwithstanding Appellants’ contentions to the contrary, however, Weiss discloses that compositions within the scope of Weiss’ disclosure, which include those within the scope of Appellants’ claimed invention, exhibit synergism (FF 5; see also FF 1—6; cf. Br. 26: Claim 1). Therefore, we are not persuaded by Appellants’ contentions regarding unexpected results (Br. 12-16). Claim 4\ Notwithstanding Appellants’ contentions to the contrary, for the reasons set forth above, the combination of Weiss and Schlatter ’103 suggest a “method according to claim 1 [] wherein the combination of active materials used in the recited method of controlling pathogenic fungal damage comprises tebuconazole, azoxystrobin, thiamethoxam, [] fludioxonil,” and tefhithrin (see FF 1—11; cf. Br. 16). CONCLUSION OF LAW The preponderance of evidence relied upon by Examiner supports a conclusion of obviousness. The rejection of claims 1 and 4, under 35 U.S.C. § 103(a) as unpatentable over the combination of Weiss and Schlatter ’103 is affirmed. Claims 2 and 6—10 are not separately argued and fall with claim 1. 9 Appeal 2016-003743 Application 12/304,823 TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 10 Copy with citationCopy as parenthetical citation